Adial Pharmaceuticals (ADIL) Institutional Ownership $1.01 +0.01 (+1.00%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Adial Pharmaceuticals (NASDAQ:ADIL)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$322.96KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$3.23M Get ADIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADIL Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Adial Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Renaissance Technologies LLC34,346$39K0.0%-32.8%0.811% 5/20/2024Virtu Financial LLC20,469$27K0.0%N/A0.484% 2/13/2024Armistice Capital LLC159,000$296K0.0%N/A9.578% 11/9/2023Manchester Capital Management LLC48,097$134K0.0%-96.0%3.942% 5/9/2023Manchester Capital Management LLC1,202,452$421K0.1%N/A4.216% 11/7/2022Virtu Financial LLC77,694$27K0.0%+142.7%0.301% Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088% 7/22/2022Truist Financial Corp33,862$45K0.0%N/A0.142% 7/13/2022 Private Advisor Group LLC21,400$29K0.0%-37.3%0.090% 11/12/2021Oppenheimer & Co. Inc.38,500$165K0.0%+37.5%0.190% 11/12/2021 NorthRock Partners LLC10,000$43K0.0%N/A0.049% 10/29/2021Commonwealth Equity Services LLC36,461$156K0.0%+25.5%0.180% 9/17/2021Virtu Financial LLC31,038$79K0.0%N/A0.153% 8/16/2021State Street Corp48,954$125K0.0%N/A0.260% 8/13/2021Northern Trust Corp21,873$56K0.0%N/A0.116% 8/13/2021Geode Capital Management LLC88,246$225K0.0%+13.2%0.469% 8/13/2021Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112% 8/11/2021Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155% 8/3/2021Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152% 7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134% 5/14/2021Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179% 5/13/2021Barclays PLC15,850$38K0.0%N/A0.091% 5/12/2021Rede Wealth LLC15,000$36K0.0%N/A0.086% 5/10/2021Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083% 5/4/2021Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126% 4/22/2021 Private Advisor Group LLC36,650$89K0.0%N/A0.212% 3/8/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% 2/25/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% 2/10/2021Renaissance Technologies LLC98,900$168K0.0%+6.5%0.687% 12/11/2020Virtu Financial LLC18,902$42K0.0%N/A0.131% (Data available from 1/1/2016 forward) ADIL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADIL shares? During the previous two years, the following institutional investors and hedge funds held shares of Adial Pharmaceuticals shares: Armistice Capital LLC ($296K), Manchester Capital Management LLC ($134K), and Renaissance Technologies LLC ($39K), Virtu Financial LLC ($27K).Learn more on ADIL's institutional investors. What percentage of Adial Pharmaceuticals stock is owned by institutional investors? 16.41% of Adial Pharmaceuticals stock is owned by institutional investors. Learn more on ADIL's institutional investor holdings. Which institutional investors have been buying Adial Pharmaceuticals stock? The following institutional investors have purchased Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.20M), Armistice Capital LLC ($159K), and Virtu Financial LLC ($66.15K). How much institutional buying is happening at Adial Pharmaceuticals? Institutional investors have bought a total of 1,427,602 shares in the last 24 months. This purchase volume represents approximately $11.24M in transactions. Which Adial Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.15M), and Renaissance Technologies LLC ($16.75K). How much institutional selling is happening at Adial Pharmaceuticals? Institutional investors have sold a total of 1,171,109 shares in the last 24 months. This volume of shares sold represents approximately $3.23M in transactions. Related Companies BioVie Major Shareholders Bright Green Major Shareholders iBio Major Shareholders GlycoMimetics Major Shareholders RenovoRx Major Shareholders Athira Pharma Major Shareholders Tempest Therapeutics Major Shareholders Unity Biotechnology Major Shareholders Pieris Pharmaceuticals Major Shareholders Spruce Biosciences Major Shareholders This page (NASDAQ:ADIL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
